tiprankstipranks
Kriti Nutrients Limited (IN:KRITINUT)
:KRITINUT
India Market
Want to see IN:KRITINUT full AI Analyst Report?

Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

0 Followers

Top Page

IN:KRITINUT

Kriti Nutrients Limited

(KRITINUT)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
₹102.00
▲(29.77% Upside)
Action:Reiterated
Date:08/09/26
The score is driven primarily by strong financial resilience (low leverage and improved cash flow) and a supportive price trend above major moving averages. Offsetting factors are meaningful margin compression that weakens earnings quality, and some near-term technical overheating risk (high stochastic). Valuation is supportive with a reasonable P/E, while the low dividend yield adds limited uplift.
Positive Factors
Low Leverage and Strong Equity Base
A conservatively financed balance sheet with debt-to-equity ~0.04 and rising equity gives durable financial flexibility. This limits refinancing risk, supports capex or working-capital needs in a commodity business, and allows management to pursue growth or weather downturns without relying on external debt.
Negative Factors
Significant Margin Compression
Sharp decline in gross and net margins indicates sustained pressure from input costs, pricing, or mix shifts. Lower margins erode earnings power and ROE, reduce reinvestment capacity, and make the business more sensitive to commodity price swings over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage and Strong Equity Base
A conservatively financed balance sheet with debt-to-equity ~0.04 and rising equity gives durable financial flexibility. This limits refinancing risk, supports capex or working-capital needs in a commodity business, and allows management to pursue growth or weather downturns without relying on external debt.
Read all positive factors

Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)

Kriti Nutrients Limited Business Overview & Revenue Model

Company Description
Kriti Nutrients Limited, established in 1992 and headquartered in Indore, India, operates in the manufacturing and global distribution of soybean seeds under its "Kriti" brand. The company's extensive product range includes various edible oils suc...
How the Company Makes Money
Kriti Nutrients Limited primarily makes money by converting oilseeds and other agri-commodities into higher-value products and selling them through B2B channels. Its key revenue streams typically include: (1) Sale of edible oils: revenue from sell...

Kriti Nutrients Limited Financial Statement Overview

Summary
Overall financials are solid, led by a very strong balance sheet (very low leverage and rising equity) and improved 2026 cash generation (operating cash flow 698.5M; free cash flow 642.8M). The key offset is weaker profitability quality: gross margin fell sharply (15.7% in 2024 to 8.1% in 2026) and net margin declined (6.6% to 3.7%) despite revenue growth.
Income Statement
68
Positive
Balance Sheet
86
Very Positive
Cash Flow
78
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.40B9.22B7.34B6.83B7.96B7.51B
Gross Profit753.15M748.03M1.03B1.07B780.37M679.84M
EBITDA482.00M434.39M557.89M666.67M356.28M222.83M
Net Income333.30M339.01M369.94M452.87M207.98M123.05M
Balance Sheet
Total Assets0.002.73B2.38B2.09B1.93B1.68B
Cash, Cash Equivalents and Short-Term Investments492.76M622.12M265.85M210.43M190.38M37.16M
Total Debt0.0091.01M30.69M121.45M403.73M375.58M
Total Liabilities-2.29B435.96M259.39M325.25M607.00M554.76M
Stockholders Equity2.29B2.29B2.12B1.76B1.32B1.13B
Cash Flow
Free Cash Flow397.30M642.82M273.10M409.62M133.43M-193.72M
Operating Cash Flow427.15M698.45M319.58M498.13M198.61M-105.10M
Investing Cash Flow-321.63M-152.65M-288.64M-291.87M-31.35M-199.81M
Financing Cash Flow13.72M-100.33M-106.49M-304.01M-14.05M311.86M

Kriti Nutrients Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price78.60
Price Trends
50DMA
81.98
Positive
100DMA
85.73
Negative
200DMA
78.21
Positive
Market Momentum
MACD
0.06
Positive
RSI
47.38
Neutral
STOCH
13.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Neutral. The current price of 78.6 is below the 20-day moving average (MA) of 85.45, below the 50-day MA of 81.98, and above the 200-day MA of 78.21, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 47.38 is Neutral, neither overbought nor oversold. The STOCH value of 13.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
₹4.20B12.310.36%21.14%3.47%
70
Outperform
₹68.02B15.8921.04%59.07%
56
Neutral
₹8.98B13.2376.01%59.13%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
₹4.22B20.390.26%15.39%27.60%
50
Neutral
₹1.31B14.4820.89%-11.15%
47
Neutral
₹1.51B32.1117.76%-50.16%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KRITINUT
Kriti Nutrients Limited
83.00
-8.72
-9.51%
IN:GOKUL
Gokul Refoils & Solvent Ltd.
42.81
2.57
6.39%
IN:GOKULAGRO
Gokul Agro Resources Ltd.
226.45
47.37
26.45%
IN:MKPL
M K Proteins Limited
4.01
-3.15
-43.99%
IN:MUKKA
Mukka Proteins Limited
30.40
1.64
5.70%
IN:ROML
Raj Oil Mills Limited
41.88
-6.42
-13.29%

Kriti Nutrients Limited Corporate Events

Kriti Nutrients Promoter Affirms No New Encumbrances on Shares in FY 2025-26
Jun 5, 2026
Sakam Trading Private Limited, a promoter company of Kriti Nutrients Limited, has declared that it and specified members of the promoter group have not created any new encumbrances on the equity shares of Kriti Nutrients during the financial year ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 09, 2026